Intellia Therapeutics, Inc. (NTLA) Buy Rating Reiterated Despite Share Offering Dilution
Intellia Therapeutics, Inc. (NASDAQ: NTLA ) is one of the most shorted mid-cap and small-cap stocks to buy now . On May 13, H.C. Wainwright reiterated Intellia Therapeutics (NASDAQ:NTLA) as a Buy but…
Yahoo Finance — 5 June 2026
Text:
7
0
0
Intellia Therapeutics, Inc. (NASDAQ: NTLA ) is one of the most shorted mid-cap and small-cap stocks to buy now . On May 13, H.C. Wainwright reiterated
Read Full Story at Yahoo Finance → Sources
📈 Markets & Finance
Sam Altman says OpenAI's top token spender uses 100 billion tokens a month — and they're not even the world leader
📈 Markets & Finance
Intel, AMD, Micron shares sink as Broadcom results spark semiconductor sector sell-off
📈 Markets & Finance
This Smart‑Money Legend Won Big on Intel. The Rest of His Portfolio Might Be Even More Revealing
📈 Markets & Finance
A new NJ bill would hand pet owners up to $900 in tax credits — and your state could be next
📈 Markets & Finance
Addressing Investor Transparency, Updates from Euronet Worldwide’s (EEFT) First Analyst Day in a Decade
📈 Markets & Finance
MGM Resorts stock jumps as Barry Diller's People Inc. makes bid to take over the company
